← All Amedisys INC filings

Amedisys INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

AMED
Amedisys INC
SCHEDULE: Pentwater Capital Exits Amedisys Stake
Pentwater Capital Management LP and Matthew Halbower report 0% beneficial ownership in Amedisys Inc. common stock.
AMED
Amedisys INC
SCHEDULE: Goldman Sachs Reports Minimal Stake in Amedisys
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC report a 0.0% beneficial ownership stake in Amedisys, Inc. common stock.
AMED
Amedisys INC
SCHEDULE: Pentwater Capital Discloses 5.2% Stake in Amedisys
Pentwater Capital Management LP and Matthew Halbower have disclosed a passive 5.2% beneficial ownership stake in Amedisys Inc.
AMED
Amedisys INC
SCHEDULE: Goldman Sachs Discloses 5.4% Stake in Amedisys
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 5.4% in Amedisys, Inc. common stock.